Keywords
Last Name
Institution

Joseph A. Odin

TitleASSOCIATE PROFESSOR
InstitutionMount Sinai
DepartmentLiver Diseases
Address5 East 98th Street
12th Floor
New York NY 10029
Phone212-241-8035

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Aliment Pharmacol Ther. 2014 Jan; 39(2):209-16.
      View in: PubMed
    2. Kesar V, Odin JA. Toll-like receptors and liver disease. Liver Int. 2014 Feb; 34(2):184-96.
      View in: PubMed
    3. Ala A, Brown D, Khan K, Standish R, Odin JA, Fiel MI, Schiano TD, Hillan KJ, Rahman SA, Hodgson HJ, Dhillon AP. Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates. Dig Dis Sci. 2013 Sep; 58(9):2528-41.
      View in: PubMed
    4. Torres J, Bao X, Iuga AC, Chen A, Harpaz N, Ullman T, Cohen BL, Pineton de Chambrun G, Asciutti S, Odin JA, Sachar DB, Gaskins HR, Setchell K, Colombel JF, Itzkowitz SH. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis. 2013 Feb; 19(2):275-82.
      View in: PubMed
    5. Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Heathcote EJ, Mason AL, Myers RP, Milkiewicz P, Odin JA, Luketic VA, Bacon BR, Bodenheimer HC, Liakina V, Vincent C, Levy C, Franke A, Gregersen PK, Bossa F, Gershwin ME, deAndrade M, Amos CI. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet. 2012 Dec 1; 21(23):5209-21.
      View in: PubMed
    6. Hu B, Allina J, Bai J, Kesar V, Odin JA. Catalase and estradiol inhibit mitochondrial protein S-glutathionylation. Mol Cell Biochem. 2012 Aug; 367(1-2):51-8.
      View in: PubMed
    7. Hirschfield GM, Xie G, Lu E, Sun Y, Juran BD, Chellappa V, Coltescu C, Mason AL, Milkiewicz P, Myers RP, Odin JA, Luketic VA, Bacon B, Bodenheimer H, Liakina V, Vincent C, Levy C, Pillai S, Lazaridis KN, Amos CI, Siminovitch KA. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun. 2012 Jun; 13(4):328-35.
      View in: PubMed
    8. Chuang N, Gross RG, Odin JA. Update on the epidemiology of primary biliary cirrhosis. Expert Rev Gastroenterol Hepatol. 2011 Oct; 5(5):583-90.
      View in: PubMed
    9. Allina J, Grabowski J, Doherty-Lyons S, Fiel MI, Jackson CE, Zelikoff JT, Odin JA. Maternal allergy acts synergistically with cigarette smoke exposure during pregnancy to induce hepatic fibrosis in adult male offspring. J Immunotoxicol. 2011 Oct-Dec; 8(4):258-64.
      View in: PubMed
    10. Singal AK, Stanca CM, Clark V, Dixon L, Levy C, Odin JA, Fiel MI, Friedman SL, Bach N. Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature. Hepatol Int. 2011 Sep; 5(3):808-13.
      View in: PubMed
    11. Hirschfield GM, Liu X, Han Y, Gorlov IP, Lu Y, Xu C, Lu Y, Chen W, Juran BD, Coltescu C, Mason AL, Milkiewicz P, Myers RP, Odin JA, Luketic VA, Speiciene D, Vincent C, Levy C, Gregersen PK, Zhang J, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet. 2010 Aug; 42(8):655-7.
      View in: PubMed
    12. Dronamraju D, Odin J, Bach N. Primary biliary cirrhosis: environmental risk factors. Dis Markers. 2010; 29(6):323-8.
      View in: PubMed
    13. Tan HH, Fiel MI, Sun Q, Guo J, Gordon RE, Chen LC, Friedman SL, Odin JA, Allina J. Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol. 2009 Dec; 6(4):266-75.
      View in: PubMed
    14. Perumalswami P, Peng L, Odin JA. Vaccination as a triggering event for autoimmune hepatitis. Semin Liver Dis. 2009 Aug; 29(3):331-4.
      View in: PubMed
    15. Hytiroglou P, Gutierrez JA, Freni M, Odin JA, Stanca CM, Merati S, Schiano TD, Branch AD, Thung SN. Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res. 2009 Jun; 39(6):577-84.
      View in: PubMed
    16. Whitt KN, Ward SC, Deniz K, Liu L, Odin JA, Qin L. Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis. 2008 May; 28(2):226-31.
      View in: PubMed
    17. Gross RG, Odin JA. Recent advances in the epidemiology of primary biliary cirrhosis. Clin Liver Dis. 2008 May; 12(2):289-303; viii.
      View in: PubMed
    18. Stanca CM, Bach N, Allina J, Bodian C, Bodenheimer H, Odin JA. Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis. Dig Dis Sci. 2008 Jul; 53(7):1988-93.
      View in: PubMed
    19. Stanca CM, Babar J, Singal V, Ozdenerol E, Odin JA. Pathogenic role of environmental toxins in immune-mediated liver diseases. J Immunotoxicol. 2008 Jan; 5(1):59-68.
      View in: PubMed
    20. Allina J, Stanca CM, Garber J, Hu B, Sautes-Fridman C, Bach N, Odin JA. Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun. 2008 Jun; 30(4):238-45.
      View in: PubMed
    21. Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME, Gores GJ, Odin JA. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun. 2006 Dec; 27(4):232-41.
      View in: PubMed
    22. Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JA, Bach N. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology. 2006 Mar; 43(3):525-31.
      View in: PubMed
    23. Stanca CM, Fiel MI, Allina J, Caracta CF, Odin JA. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis. 2005 Aug; 25(3):364-70.
      View in: PubMed
    24. Stanca CM, Bach N, Krause C, Tandon N, Freni MA, Gutierrez JA, Bodian C, Lopez J, Berk PD, Bodenheimer HC, Branch AD, Odin JA. Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol. 2005 May; 100(5):1104-9.
      View in: PubMed
    25. Mao TK, Davis PA, Odin JA, Coppel RL, Gershwin ME. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology. 2004 Dec; 40(6):1241-8.
      View in: PubMed
    26. Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, Odin JA, Diehl JA, Germain D, Friedman SL. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res. 2004 Jun 1; 64(11):3885-91.
      View in: PubMed
    27. Matsumura S, Van De Water J, Leung P, Odin JA, Yamamoto K, Gores GJ, Mostov K, Ansari AA, Coppel RL, Shiratori Y, Gershwin ME. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology. 2004 May; 39(5):1415-22.
      View in: PubMed
    28. Bach N, Odin JA. Primary biliary cirrhosis: a Mount Sinai perspective. Mt Sinai J Med. 2003 Sep; 70(4):242-50.
      View in: PubMed
    29. Bai J, Odin JA. Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun Rev. 2003 Jan; 2(1):36-42.
      View in: PubMed
    30. Sasaki M, Allina J, Odin JA, Thung SN, Coppel R, Nakanuma Y, Gershwin ME. Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol. 2002 Jun; 9(2):103-11.
      View in: PubMed
    31. Mahoney JA, Odin JA, White SM, Shaffer D, Koff A, Casciola-Rosen L, Rosen A. The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. Biochem J. 2002 Feb 1; 361(Pt 3):587-95.
      View in: PubMed
    32. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 2001 Jul; 108(2):223-32.
      View in: PubMed
    33. Sédat J, Dib M, Odin J, Pédulla F, Aboulker C, Santini J. [Endovascular embolization of ophthalmic artery branches for control of refractory epistaxis: report of one case]. J Radiol. 2001 Jun; 82(6 Pt 1):670-2.
      View in: PubMed
    34. Skowron O, Descotes JL, Stanke F, Baudot A, Riebel D, Bessard G, Egelhoffer H, Mazuer J, Odin J. Comparison between the reactivities of fresh, preserved at 4 degrees C and cryopreserved abdominal aortae of the rabbit. Transplant Proc. 1998 Sep; 30(6):2847-8.
      View in: PubMed
    35. Peyridieu JF, Baudot A, Boutron P, Mazuer J, Odin J, Ray A, Chapelier E, Payen E, Descotes JL. Critical cooling and warming rates to avoid ice crystallization in small pieces of mammalian organs permeated with cryoprotective agents. Cryobiology. 1996 Aug; 33(4):436-46.
      View in: PubMed
    36. Descotes JL, Payen E, Skowron O, Peyridieu J, Baudot A, Mazuer J, Odin J, Dupeyre R, Delon-Martin C, Décorps M, Jakob P, Kober F. Cryopreservation of organs: NMR follow-up of cryoprotectant perfusion in rabbit kidneys. Transplant Proc. 1996 Feb; 28(1):346-8.
      View in: PubMed
    37. Descotes JL, Payen E, Rambeaud JJ, Peuridieu JF, Baudot A, Odin J, Mazuer J, Boutron P, Delon-Martin C, Dupeyre R, et al. [Organ cryopreservation: current status of research carried out in Grenoble]. Prog Urol. 1995 Dec; 5(6):927-31; discussion 931-2.
      View in: PubMed
    38. Zhang F, Yang B, Odin JA, Shen Z, Lin CT, Unkeless JC, Jacobson K. Lateral mobility of Fc gamma RIIa is reduced by protein kinase C activation. FEBS Lett. 1995 Nov 27; 376(1-2):77-80.
      View in: PubMed
    39. Descotes JL, Payen E, Chapelier E, Rambeaud JJ, Ferrari M, Mazuer J, Odin J. Cold and warm renal ischemia and postoperative survival in rabbits with autotransplanted kidneys. Transplant Proc. 1995 Oct; 27(5):2874-6.
      View in: PubMed
    40. Boros P, Odin JA, Chen J, Unkeless JC. Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease. J Immunol. 1994 Jan 1; 152(1):302-6.
      View in: PubMed
    41. Odin JA, Edberg JC, Painter CJ, Kimberly RP, Unkeless JC. Regulation of phagocytosis and [Ca2+]i flux by distinct regions of an Fc receptor. Science. 1991 Dec 20; 254(5039):1785-8.
      View in: PubMed
    42. Boros P, Odin JA, Muryoi T, Masur SK, Bona C, Unkeless JC. IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation. J Exp Med. 1991 Jun 1; 173(6):1473-82.
      View in: PubMed
    43. Qu ZX, Odin J, Glass JD, Unkeless JC. Expression and characterization of a truncated murine Fc gamma receptor. J Exp Med. 1988 Mar 1; 167(3):1195-210.
      View in: PubMed
    Odin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067